Real-time enrollment status for this bladder cancer clinical trial
Current Status
Recruiting
Checked: July 22, 2026 at 10:40 PM UTC
| NCT Number | NCT07222488 |
| Recruiting Status | Recruiting |
| Condition | Bladder Cancer |
| Phase | PHASE1 |
| Target Enrollment | 45 participants |
| Active Locations | 2 sites in the US |
| Sponsor | Merck Sharp & Dohme LLC |
| Last Updated on CT.gov | July 17, 2026 (5 days ago) |
As of July 22, 2026: Clinical trial NCT07222488 is currently recruiting participants. This phase1 study for bladder cancer is actively seeking new participants at 2 locations across the United States. The study is sponsored by Merck Sharp & Dohme LLC. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07222488 is actively recruiting participants as of July 22, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 2 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07222488 was last updated 5 days ago (July 17, 2026). HelloStudys verifies this status automatically.